Indian Stock Market News, Equity Market and Sensex Today in India | Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks


Login Failure
(Please do not use this option on a public machine)
  Sign Up | Forgot Password?  

Indian Indices End on a Strong Note; Sensex Ends 379 Points Higher
Tue, 5 Mar Closing | Monish Vora, TM Team

After opening the day marginally lower, Indian share markets witnessed most of the buying interest during closing hours and ended on a strong note. Gains were seen in the metal sector, oil & gas sector and automobiles sector, while IT stocks witnessed selling pressure.

At the closing bell, the BSE Sensex stood higher by 379 points (up 1.1%) and the NSE Nifty closed higher by 124 points (up 1.1%). The BSE Mid Cap index ended the day up 2% and the BSE Small Cap index ended the day up by 3.1%.

Asian stock markets finished on a mixed note. As of the most recent closing prices, the Hang Seng was up by 0.1% and the Shanghai Composite was up by 0.9%. The Nikkei 225 was down 0.4%.

The rupee was trading at 70.52 against the US$.

The rupee appreciated by 11 paise to 70.81 against the US$ in opening trade today, driven by weakening of the greenback in overseas markets and fresh foreign inflows.

So far this year, the rupee has declined 1.6% while foreign investors have bought $2.3 billion in equity and sold $1.7 billion in debt market.

In the news from the mutual funds space, Indian securities market regulator board has approved changes in its norms for open offer exemptions for corporates facing debt restructuring as also for debt instrument valuation by mutual funds to make these processes fairer.

As per the news, the regulator will amend its norms for valuation of money market and debt securities by mutual funds to make the process fairer and uniform across the industry to safeguard investors from default like scenarios.

The proposal seeks to make the valuation practices more reflective of the realizable value of money market and debt securities with residual maturity up to 60 days.

Accordingly, the residual maturity limit for amortization-based valuation by mutual funds will be reduced from 60 days to 30 days.

The threshold maintained between reference price and valuation price would be plus or minus 0.025%, while the reference price will be taken as security level price given by the valuation agencies.

The above process will bring in fairness and transparency in the valuation of securities by mutual funds and thus bodes well for the mutual fund investors.

Also, speaking of mutual funds, the ghosts of the IL&FS crisis continue to haunt Indian mutual funds. More so, when it comes to their debt exposure.

Debt mutual fund managers have been facing a tough time due to tight liquidity post the IL&FS crisis.

The credit risk of their assets has shot up in the aftermath of the crisis. So ideally, to offset this rising credit risk, funds should have piled up on risk-free government bonds.

However, it turns out that mutual funds have been net sellers of government bonds since the beginning of 2018.

And the intensity of the selling has only increased in the months following September 2018.

As a percentage of their total assets under management, government security exposure has dropped to 3.3% by January 2019, from 5.4% in August 2018.

Mutual Funds Playing with Fire with Steep Corporate Debt Exposure

Here's what Tanushree Banerjee wrote about this in today's edition of The 5 Minute WrapUp...

  • Instead, in the greed of marginally higher yields from risky corporate borrowers (compared to G-Sec yields), funds are piling up on corporate debt.

    Keep in mind that corporate debt papers are not only relatively riskier but also comparatively illiquid. By exposing investors to such risk without their knowledge, debt fund managers are doing them a huge disservice.

In the news from pharma space, Cadila Healthcare share price was in focus today as the company received the United States Food and Drug Administration (USFDA) approval to market Rivastigmine Transdermal System. This marks the company's first approval for a transdermal product in the US.

The company in a filing said that Rivastigmine Transdermal System is indicated for the treatment of dementia (memory loss) associated with Alzheimer's and Parkinson's diseases. It will be manufactured at Zydus Technologies Ltd, the group's manufacturing facility dedicated to the production oftransdermals, located at SEZ, Ahmedabad.

Last month, the company received the final approval from the USFDA to market Triamterene and Hydrochlorothiazide Capsules USP (US RLD-DYAZIDE), 37.5 mg/25 mg.

To know more about the company, you can read Cadila Healthcare Q3FY19 result analysis and Cadila Healthcare Annual report analysis on our website.

Speaking of pharma sector, note that the BSE Healthcare Index has been on a roller coaster ride in the past few years. The period from 2012 to 2015 saw the index go up more than three times.

And since then it has been a painful ride downwards.

As we wrote in one of our editions of The 5 Minute WrapUp...

  • Pre-2015, pharma companies enjoyed a fairytale ride in the US market. Low labor costs, good chemistry skills, along with efficiency, ensured Indian companies could copy innovator drugs to make generic drugs at a fast pace.

    The generic business had lucrative margins for all major pharma players. But the party did not last long. In the quest to supply drugs quickly, they compromised on quality at their manufacturing facilities.

    No wonder, the US regulatory authority (USFDA) took strict action. Sun Pharma received a warning letter for its Halol manufacturing facility in 2015. It was like a bolt out of the blue. Since then, the downward spiral began and has continued till date.

We believe that pharma companies that invest in creating a pipeline of complex generics or building competencies in alternative dosage forms are better equipped to tackle the changing dynamics in the US generics market as well as in the overall industry.

To know more on what moved the Indian stock markets today, you can check out the most recent share market updates here.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

What else is happening in the markets today? Dig in...

Equitymaster requests your view! Post a comment on "Indian Indices End on a Strong Note; Sensex Ends 379 Points Higher". Click here!


Stock Market Updates

TUBE INVESTMENTS OF INDIA LTD Share Price Up by 5%; BSE CAPITAL GOODS Index Up 0.5% (Today's Market)

Aug 7, 2020 03:34 PM

TUBE INVESTMENTS OF INDIA LTD share price is trading up by 5% and its current market price is Rs 558. The BSE CAPITAL GOODS is up by 0.5%. The top gainers in the BSE CAPITAL GOODS Index are TUBE INVESTMENTS OF INDIA LTD (up 5.2%) and HONEYWELL AUTOMATION (up 14.2%). The top losers are V GUARD INDUSTRIES (down 0.2%) and SKF INDIA (down 0.3%).

BANK OF BARODA Share Price Up by 5%; BSE BANKEX Index Up 0.4% (Today's Market)

Aug 7, 2020 03:34 PM

BANK OF BARODA share price is trading up by 5% and its current market price is Rs 49. The BSE BANKEX is up by 0.4%. The top gainers in the BSE BANKEX Index are BANK OF BARODA (up 5.1%) and RBL BANK LTD (up 9.7%). The top losers are AXIS BANK and SBI (down 0.2%).

ADANI TRANSMISSION Share Price Up by 9%; BSE POWER Index Up 1.4% (Today's Market)

Aug 7, 2020 03:34 PM

ADANI TRANSMISSION share price is trading up by 9% and its current market price is Rs 254. The BSE POWER is up by 1.4%. The top gainers in the BSE POWER Index are ADANI TRANSMISSION (up 9.0%) and JSW ENERGY (up 5.3%). The top losers are NTPC (down 0.3%) and KALPATARU POWER (down 0.5%).

ESSEL PROPACK Share Price Down by 5%; BSE 500 Index Up 0.3% (Today's Market)

Aug 7, 2020 03:14 PM

ESSEL PROPACK share price is trading down by 5% and its current market price is Rs 275. The BSE 500 is up by 0.3%. The top gainers in the BSE 500 Index are HONEYWELL AUTOMATION (up 11.7%) and RBL BANK LTD (up 10.0%). The top losers are ESSEL PROPACK (down 5.0%) and LUPIN (down 6.0%).

EMAMI LTD Share Price Up by 6%; BSE FMCG Index Up 0.8% (Today's Market)

Aug 7, 2020 02:26 PM

EMAMI LTD share price is trading up by 6% and its current market price is Rs 254. The BSE FMCG is up by 0.8%. The top gainers in the BSE FMCG Index are EMAMI LTD (up 6.2%) and GSK CONSUMER (up 5.1%). The top losers [TOPLOSERS].

Sensex Trades Marginally Lower; HCL Technologies & Infosys Top Losers (Today's Market)

Aug 7, 2020 12:30 pm

The BSE Sensex is trading down by 83 points, while the NSE Nifty is trading down by 18 points.

View More Indian Share Market News

Most Popular

These 5 Smallcaps Deserve a Place in Your Coffee Can Portfolio(Profit Hunter)

Jul 28, 2020

When it comes to quality stocks, doing less is more.

Before You Buy Your First Electric Vehicle Consider Buying this Stock(Profit Hunter)

Jul 29, 2020

As competition intensifies in the electric vehicle space, only few will create huge wealth over the years.

How to Buy Gold and Silver(Fast Profits Daily)

Jul 27, 2020

In this video I'll show you how to buy bullion the right way.

Elon Musk Gives Us a Trading Opportunity(Fast Profits Daily)

Jul 28, 2020

Elon Musk made a statement recently which I believe, gives us a fast profit trading opportunity.


Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms


Aug 7, 2020 (Close)